AMENDMENT TO LICENSE AGREEMENTLicense Agreement • November 14th, 2019 • Wize Pharma, Inc. • Pharmaceutical preparations
This agreement (the “Amendment”) is entered into on November 8, 2019 (the "Effective Date"), by and between Resdevco Research and Development Company Ltd., reg. no. 510422223 (the "Licensor") and Wize Pharma Ltd., reg. no. 520033259, the former name of which is Star Night Technologies Ltd. (the “Licensee”) (the Licensor and the Licensee, each a “Party” and shall be collectively referred to hereinafter as the "Parties").
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 14th, 2019 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is dated as of September 4, 2019 (the “Agreement Date”) and is entered into by and between Copernicus Therapeutics, Inc., a Delaware corporation (“Copernicus” or “Licensor”), and Wize Pharma, Inc., a Delaware corporation (“Wize” or “Licensee”).
